John Hopper

Australian epidemiologist

DBpedia resource is: http://dbpedia.org/resource/John_Hopper_(scientist)

Abstract is: John L. Hopper is an Australian genetic epidemiologist and professor at the University of Melbourne, where he is a Professorial Fellow and Director of the Centre for Epidemiology and Biostatistics in the School of Population Global Health. He is also a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow, and was one of the first nine Australia Fellows chosen by the NHMRC in 2007. Since 1990, he has been the director of Twins Research Australia (formerly the Australian Twin Registry).

John Hopper is …
instance of (P31):
humanQ5

External links are
P2671Google Knowledge Graph ID/g/11gr6vtmpm
P1960Google Scholar author IDi9GTRzQAAAAJ
P496ORCID iD0000-0002-8567-173X
P1153Scopus author ID7201924128
P8207The Conversation author ID1429
P1556zbMATH author IDhopper.john-llewelyn

P27country of citizenshipAustraliaQ408
P69educated atMonash UniversityQ598841
La Trobe UniversityQ1478723
P108employerUniversity of MelbourneQ319078
P734family nameHopperQ21501617
HopperQ21501617
HopperQ21501617
P101field of workgenetic epidemiologyQ5532897
P735given nameJohnQ4925477
JohnQ4925477
LlewelynQ21503586
LlewelynQ21503586
P106occupationresearcherQ1650915
statisticianQ2732142
geneticistQ3126128
epidemiologistQ13416803
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q6411528410-year performance of four models of breast cancer risk: a validation study
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3578591114th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer Dallas, TX, USA. 12-13 October 2010. Abstracts
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q4005296420/20--Alcohol and age-related macular degeneration: the Melbourne Collaborative Cohort Study
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q57945242350 HFE C282Y HOMOZYGOSITY IS ASSOCIATED WITH AN INCREASED RISK OF TOTAL HIP REPLACEMENT FOR OSTEOARTHRITIS IN MEN BUT NOT WOMEN
Q545694285alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q47953281A 12-month prospective study of the relationship between stress fractures and bone turnover in athletes
Q51569689A BRCA1 promoter variant (rs11655505) and breast cancer risk.
Q57100437A Comparison of Adiposity Measures as Predictors of All-cause Mortality: The Melbourne Collaborative Cohort Study*
Q53283615A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics.
Q34613667A PALB2 mutation associated with high risk of breast cancer
Q57265744A Systematic Approach to Analysing Gene-Gene Interactions: Polymorphisms at the Microsomal Epoxide Hydrolase EPHX and Glutathione S-transferase GSTM1, GSTT1, and GSTP1 Loci and Breast Cancer Risk
Q34175965A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk
Q61132431A co-twin study of the effect of calcium supplementation on bone density during adolescence
Q34015399A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics
Q104471089A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q57100446A comparison of different methods for including 'age at menopause' in analyses of the association between hormone replacement therapy use and breast cancer
Q45399914A comparison of self-reported and record-linked blood donation history in an Australian cohort
Q35957063A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
Q28384136A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services
Q41455686A family study of panic disorder
Q41982877A family study of panic disorder: reanalysis using a regressive logistic model that incorporates a sibship environment
Q42667209A genetic and environmental analysis of a twin family study of alcohol use, anxiety, and depression
Q37272982A genome wide linkage search for breast cancer susceptibility genes
Q36395306A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1.
Q56436562A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
Q29417036A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
Q35889669A genome-wide linkage study of mammographic density, a risk factor for breast cancer
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q35089479A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Q36435849A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Q36477652A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Q36512734A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry
Q92711687A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Q35626744A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer
Q37399509A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis
Q34737151A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study
Q39680659A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide
Q35699278A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Q49056658A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
Q48715331A prospective population-based study of menopausal symptoms.
Q44012585A prospective study of bone loss in menopausal Australian-born women
Q57265807A protein-truncating mutation inCYP17A1 in three sisters with early-onset breast cancer
Q31109774A range of simple summary genome-wide statistics for detecting genetic linkage using high density marker data
Q37632049A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact
Q37599352A role for XRCC2 gene polymorphisms in breast cancer risk and survival
Q34998516A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q42598301A twin study of genetic influences on epilepsy outcome
Q29417157A variant in FTO shows association with melanoma risk not due to BMI
Q36043159ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry
Q56438288AT-tributable risks?
Q57188445AVERAGE VOLUME OF ALCOHOL CONSUMED, TYPE OF BEVERAGE, DRINKING PATTERN AND THE RISK OF DEATH FROM ALL CAUSES
Q34172196Abdominal obesity and age-related macular degeneration
Q51582208Abridged adapter primers increase the target scope of Hi-Plex.
Q61782514Abstract 32: Lynch syndrome-associated breast cancers: Clinicopathological characteristics of a case series from the Colon CFR
Q58047207Abstract 4831: Additive and multiplicative gene-environment interactions for colorectal cancer risk
Q57785674Abstract LB-282: Transethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A
Q57637098Acceptability and Usability of iPrevent�, a Web-Based Tool for Assessment and Management of Breast Cancer Risk. (Preprint)
Q92102602Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
Q36422294Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults
Q68117480Acute stroke outcome: effects of stroke type and risk factors
Q33912818Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study
Q35219159Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
Q50977654Adult serum cytokine concentrations and the persistence of asthma.
Q24535695After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer
Q56437837AfterhMSH2 andhMLH1?what next? Analysis of three-generational, population-based, early-onset colorectal cancer families
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q34644094Age-dependent associations between androgenetic alopecia and prostate cancer risk
Q53021229Age-related macular degeneration in ethnically diverse Australia: Melbourne Collaborative Cohort Study.
Q58613780Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Q51028293Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry.
Q46455507Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry
Q39218432Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
Q52291866Alcohol consumption and cardiovascular mortality accounting for possible misclassification of intake: 11-year follow-up of the Melbourne Collaborative Cohort Study.
Q57265769Alcohol consumption and prostate cancer risk: Results from the Melbourne collaborative cohort study
Q44143065Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study
Q30779634Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases
Q44640070Alcohol consumption for different periods in life, intake pattern over time and all-cause mortality
Q41088489Alcohol use, smoking habits and the Adult Eysenck Personality Questionnaire in adolescent Australian twins [corrected]
Q30747351Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease
Q33636690Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry
Q46011428Ambient wood smoke exposure and respiratory symptoms in Tasmania, Australia.
Q39428233Ambient wood smoke, traffic pollution and adult asthma prevalence and severity
Q36073563An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
Q46063050An inverse association between ovarian cysts and breast cancer in the breast cancer family registry
Q52585935An open-source, integrated pedigree data management and visualization tool for genetic epidemiology.
Q34308746Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families
Q34480599Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource
Q44204316Analysis of dynamic computed tomography scan brain images
Q38378456Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour
Q70568011Analysis of variation in blood lead levels in Melbourne families
Q42653120Analytical and graphical methods to model the association between family history and disease from a case-control study
Q45980590Analyzing the etiology of benign rolandic epilepsy: a multicenter twin collaboration.
Q57269082Androgen receptor exon 1 cag repeat length and risk of ovarian cancer
Q34523806Androgenetic alopecia and prostate cancer: findings from an Australian case-control study
Q28191418Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
Q61442784Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations
Q57100196Apolipoprotein E Gene Associations in Age-related Macular Degeneration: The Melbourne Collaborative Cohort Study
Q36008157Application of genetics to the prevention of colorectal cancer.
Q45763447Architecture of cortical bone determines in part its remodelling and structural decay
Q57305998Are PALB2 mutations associated with increased risk of male breast cancer?
Q57265609Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?
Q41661586Are obesity and body fat distribution associated with low back pain in women? A population-based study of 1128 Spanish twins
Q100387828Are the Relationships of Lean Mass and Fat Mass With Bone Microarchitecture Causal or Due to Familial Confounders? A Novel Study of Adult Female Twin Pairs
Q36763034Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Q36787357Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
Q36294966Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome
Q39164029Assessing and managing breast cancer risk: clinicians' current practice and future needs
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q64940233Assessing patient readiness for personalized genomic medicine.
Q56893420Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies
Q88159791Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study
Q64056497Association analyses identify 31 new risk loci for colorectal cancer susceptibility
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q37623732Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease
Q51399486Association analysis of oestrogen receptor beta gene (ESR2) polymorphisms with female pattern hair loss.
Q40317688Association between DNA methylation at SOCS3 gene and body mass index might be due to familial confounding
Q58298117Association between birth weight and educational attainment: an individual-based pooled analysis of nine twin cohorts
Q38860166Association between birthweight and later body mass index: an individual-based pooled analysis of 27 twin cohorts participating in the CODATwins project
Q35920915Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype
Q37192664Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer
Q39791494Association between selected dietary scores and the risk of urothelial cell carcinoma: A prospective cohort study
Q47903752Association of DNA Methylation-Based Biological Age with Health Risk Factors, and Overall and Cause-Specific Mortality
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q46707380Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis
Q35246178Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants
Q47191928Association of birth weight and current body size to blood pressure in female twins
Q37684672Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Q57543292Association of current and former smoking with body mass index: A study of smoking discordant twin pairs from 21 twin cohorts
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q114182713Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Q52587998Associations between birth size and later height from infancy through adulthood: An individual based pooled analysis of 28 twin cohorts participating in the CODATwins project.
Q37382206Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status
Q47232610Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women
Q47690269Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q54679615Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer.
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q57265673Asthma, Asthma Medications, and Prostate Cancer Risk
Q30485831Australian Twin Registry: 30 years of progress
Q57297338Australian Twin Registry: A Nationally Funded Resource for Medical and Scientific Research, Incorporating match and WATCH
Q53242830Australian Twin Registry: a nationally funded resource for medical and scientific research, incorporating match and WATCH.
Q37204722Australian clinicians and chemoprevention for women at high familial risk for breast cancer
Q44953939Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics
Q24531993Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
Q34782265BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome
Q37416050BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research
Q34571646BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Q36420531BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study
Q38914005BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q57306056BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk
Q42506232BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Q56995151Background, rationale and protocol for a case-control-family study of breast cancer
Q44357049Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast
Q52576402Birth size and gestational age in opposite-sex twins as compared to same-sex twins: An individual-based pooled analysis of 21 cohorts.
Q38864714Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study
Q41066127Blood pressure in subjects from rural Greece, comparing individuals migrating to Melbourne, Australia with non-migrant relatives
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q30502502Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes
Q34883523Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers
Q47367583Body size and composition and colon cancer risk in women
Q47313556Body size and composition and risk of rectal cancer (Australia).
Q47357608Body size and composition and the risk of gastric and oesophageal adenocarcinoma
Q47373087Body size and composition and the risk of lymphohematopoietic malignancies
Q38403904Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis
Q47412578Body size, weight change, and risk of colon cancer
Q36794730Bone density determinants in elderly women: a twin study
Q71665300Bone mineral density and hormone levels in menopausal Australian women
Q71477234Bone turnover markers and bone density across the menopausal transition
Q57265621Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Q48175282Breast Cancer Risk Associations with Digital Mammographic Density by Pixel Brightness Threshold and Mammographic System.
Q36619329Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry
Q43073201Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
Q57265906Breast cancer in Australian women under the age of 40
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q51003387Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2.
Q35609710Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry
Q37410693Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q44937823Breast cancer risks for BRCA1/2 carriers
Q57305977Breast-Cancer Risk in Families With Mutations in PALB2
Q34148873Breast-cancer risk in families with mutations in PALB2
Q40044786Bronchial hyperresponsiveness and obesity in middle age: insights from an Australian cohort
Q41004860CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q24810733CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Q73088381CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
Q36419325CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Q36750746CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
Q44793797Can genetic associations change with age? CFH and age-related macular degeneration
Q92005489Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Q57265774Cancer Risks For Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family Study
Q51726517Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
Q30563768Cancer risks for MLH1 and MSH2 mutation carriers
Q30461804Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer
Q37700797Cancer risks for relatives of children with cancer
Q36369233Cancer risks for relatives of patients with serrated polyposis
Q28385765Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Q33736763Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status
Q49874632Causal effect of smoking on DNA methylation in peripheral blood: a twin and family study.
Q57305951Causes of blood methylomic variation for middle-aged women measured by the HumanMethylation450 array
Q72595861Cerebral hypoperfusion in stroke prognosis and brain recovery
Q38533169Changes in axial bone density with age: a twin study
Q50677600Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins.
Q44228291Changes in physical activity and health outcomes in a population-based cohort of mid-life Australian-born women
Q58104811Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study
Q40892499Childhood body mass index and adult mammographic density measures that predict breast cancer risk
Q36244800Childhood cancers in families with and without Lynch syndrome
Q57599233Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle age
Q40371861Childhood immunization and atopic disease into middle-age--a prospective cohort study
Q37078547Childhood infections and adult height in monozygotic twin pairs
Q47968216Childhood infections and the risk of asthma: a longitudinal study over 37 years
Q51761040Childhood measles contributes to post-bronchodilator airflow obstruction in middle-aged adults: A cohort study.
Q52599973Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.
Q51725781Childhood wheeze phenotypes show less than expected growth in FEV1 across adolescence.
Q40707751Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.
Q36599631Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG
Q56994835Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer
Q57265750Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer
Q35287715Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies
Q46569800Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition
Q43189592Circulating steroid hormone levels and risk of breast cancer for postmenopausal women
Q46910105Circulating steroid hormones and the risk of prostate cancer
Q37254403Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics
Q57306048Clinical Classification ofBRCA1andBRCA2DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis—A Report From the kConFab Investigators
Q39683513Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study
Q40706266Cohort Profile: Melbourne Atopy Cohort study (MACS).
Q37219731Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)
Q56379999Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC)
Q40149181Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020).
Q40641928Cohort Profile: The Tasmanian Longitudinal Health STUDY (TAHS).
Q53226230Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.
Q35925149Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study
Q36000794Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.
Q28284149Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
Q55520252Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance.
Q94486442Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
Q40594667Commentary: Case-control-family designs: a paradigm for future epidemiology research?
Q47322321Common Pediatric Pain Disorders and Their Clinical Associations
Q36839777Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Q34394665Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction
Q35889575Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Q36600605Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk
Q33742096Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
Q43166839Common genetic variants associated with breast cancer and mammographic density measures that predict disease
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q37371151Common sequence variants on 20q11.22 confer melanoma susceptibility
Q36393232Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Q35870067Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q37434133Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Q34792833Common variants in ZNF365 are associated with both mammographic density and breast cancer risk
Q29417133Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
Q33679480Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q40718941Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations
Q36315747Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer
Q37121925Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics
Q36026731Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q33959070Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.
Q33700463Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity
Q33646285Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer
Q43244689Consumption of animal products, their nutrient components and postmenopausal circulating steroid hormone concentrations
Q37577739Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Q35029565Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
Q34102586Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer
Q55257640Correction: Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22.
Q57266620Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q45812067Correlations between cerebral arterial velocities, blood flow, and delayed ischemia after subarachnoid hemorrhage
Q49498050Corrigendum: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
Q50240714Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci.
Q48526678Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Q38687607Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
Q67910152Costs and benefits of the use of commercial market research approaches in large scale surveys
Q28388475Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Q72486756Crossed cerebellar diaschisis and brain recovery after stroke
Q37409157Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals
Q37194155Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study
Q36694276Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study
Q21144874DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
Q90858079DNA methylation-based biological age, genome-wide average DNA methylation, and conventional breast cancer risk factors
Q48192088DNA methylation-based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
Q37685729DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Q92831013DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility
Q43218563De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation
Q37332239Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer
Q40270211Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer
Q35587019Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes
Q40760869Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).
Q36803796Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?
Q44581219Determinants of bone density in 30- to 65-year-old women: a co-twin study
Q36687318Determinants of bone mass in 10- to 26-year-old females: A twin study
Q61132491Determinants of hip axis length in women aged 10–89 years: A twin study
Q51802404Determinants of preferences for genetic counselling in Jewish women.
Q49846654Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.
Q35872667Determining the familial risk distribution of colorectal cancer: a data mining approach.
Q36217478Determining the frequency of de novo germline mutations in DNA mismatch repair genes
Q40712359Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors
Q44609956Diabetes, hyperinsulinemia, and hyperlipidemia in small aboriginal community in northern Australia
Q33588213Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers
Q31155090Diet and exercise during growth have site-specific skeletal effects: a co-twin control study
Q57265592Dietary Intake of B Vitamins and Methionine and Colorectal Cancer Risk
Q46516453Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer
Q43498594Dietary intake of B vitamins and methionine and breast cancer risk
Q57265625Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality
Q57265626Dietary intake of B vitamins and methionine and risk of lung cancer
Q49990651Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
Q50594346Dietary patterns and prostate cancer risk.
Q34627774Dietary patterns and risk of breast cancer
Q44643595Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study
Q34115013Differences in drinking patterns associated with migration from a Greek island to Melbourne, Australia: a study of sibships
Q38692419Differences in genetic and environmental variation in adult BMI by sex, age, time period, and region: an individual-based pooled analysis of 40 twin cohorts
Q46763107Disclosing genetic research results: experiences of the Colon Cancer Family Registry
Q60472142Discovery of common and rare genetic risk variants for colorectal cancer
Q34662485Disease-specific prospective family study cohorts enriched for familial risk
Q43642380Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Q34069646Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study
Q30571269Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data
Q33593851Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?
Q36615581Does smoking among friends explain apparent genetic effects on current smoking in adolescence and young adulthood?
Q33612493Does the sex of one's co-twin affect height and BMI in adulthood? A study of dizygotic adult twins from 31 cohorts
Q45171190Domestic airborne pollutants and asthma and respiratory symptoms in middle age.
Q45207103Dynamic CT brain scanning in the haemodynamic evaluation of cerebral arterial occlusive disease
Q28208394ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer
Q46853263Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots
Q47175049Early growth, adult body size and prostate cancer risk
Q43605844Early seizures after acute stroke. Risk of late seizures
Q57265659Early-life sun exposure and risk of melanoma before age 40 years
Q50012629Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
Q45069217Education in Twins and Their Parents Across Birth Cohorts Over 100 years: An Individual-Level Pooled Analysis of 42-Twin Cohorts
Q68461392Effect of early menopause on bone mass in normal women and patients with osteoporosis
Q53408150Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.
Q39443485Efficacy of a Sleep Quality Intervention in People With Low Back Pain: Protocol for a Feasibility Randomized Co-Twin Controlled Trial
Q40266305Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study
Q45073555Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data
Q47196130Epigenetic supersimilarity of monozygotic twin pairs
Q57265567Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer
Q50895975Epilepsies in twins: genetics of the major epilepsy syndromes.
Q55481904Epilepsy and primary cerebral tumours.
Q30920805Epilepsy in twins: insights from unique historical data of William Lennox
Q43545423Epileptic seizures in acute stroke
Q55208680Erratum to: Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study.
Q42412214Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q57202568Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk
Q57265517Erratum: Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study [Corrigendum]
Q53075668Estimates of familial risks from family data are biased when ascertainment of families is not independent of family history.
Q36990074Estimating cumulative risks for breast cancer for carriers of variants in uncommon genes
Q33763770Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.
Q34767345Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer
Q59292166Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants
Q57306021Estrogen Receptor Polymorphism at Codon 325 and Risk of Breast Cancer in Women Before Age Forty
Q57100396Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
Q37481884Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
Q33894527Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q36070164Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer
Q73286319Evidence for genetic associations between asthma, atopy, and bronchial hyperresponsiveness: a study of 8- to 18-yr-old twins
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q45918948Explaining variance in the cumulus mammographic measures that predict breast cancer risk: a twins and sisters study.
Q50871791Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Q34209800FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q33949054FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles
Q36886224Factors in childhood as predictors of asthma in adult life
Q45201853Factors influencing asthma remission: a longitudinal study from childhood to middle age.
Q57265888Familial Patterns of Covariation for Cardiovascular Risk Factors in Adults: The Victorian Family Heart Study
Q57306010Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations
Q44325842Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale
Q52553115Familial and genomic analyses of postural changes in systolic and diastolic blood pressure.
Q43256458Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study
Q71444475Familial temporal lobe epilepsy: a common disorder identified in twins
Q37308563Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry
Q33625221Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases
Q57265514Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
Q45137915Family-based association study of IGF1 microsatellites and height, weight, and body mass index
Q51811339Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
Q36397847Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36068167Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q35056061Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes
Q35063160Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q37002930Five endometrial cancer risk loci identified through genome-wide association analysis
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q44768684Foods, nutrients and prostate cancer
Q44326161Fracture risk and height: an association partly accounted for by cortical porosity of relatively thinner cortices
Q39260899Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study
Q34756357Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases
Q44770755Frequency of ejaculation and risk of prostate cancer
Q46060108From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q47822741Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling
Q34406143Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci
Q40137431Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Q47812751Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss
Q74426396Genes and family environment explain correlations between blood pressure and body mass index
Q33994469Genes involved with folate uptake and distribution and their association with colorectal cancer risk
Q37389405Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Q41598426Genetic analysis of systolic blood pressure in Melbourne families
Q40363977Genetic and Environmental Causes of Variation in the Difference Between Biological Age Based on DNA Methylation and Chronological Age for Middle-Aged Women
Q38376969Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study
Q57306006Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance
Q100943997Genetic and environmental causes of variation in epigenetic aging across the lifespan
Q54202681Genetic and environmental factors affecting birth size variation: a pooled individual-based analysis of secular trends and global geographical differences using 26 twin cohorts.
Q37503420Genetic and environmental influences on adult human height across birth cohorts from 1886 to 1994.
Q94687003Genetic and environmental influences on human height from infancy through adulthood at different levels of parental education
Q51802906Genetic and environmental influences on variation in balance performance among female twin pairs aged 21-82 years.
Q46653715Genetic and environmental variances of bone microarchitecture and bone remodeling markers: a twin study
Q60310914Genetic and environmental variation in Eysenck Personality Questionnaire scales measured on Australian adolescent twins
Q98164511Genetic and environmental variation in educational attainment: an individual-based analysis of 28 twin cohorts
Q35578513Genetic determinants of bone mass in adults. A twin study
Q35999323Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
Q49111373Genetic factors associated with altered sodium transport in human hypertension: a twin study.
Q51611349Genetic factors in bone turnover.
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q54940815Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Q90436522Genetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer
Q37281843Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q52561250Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
Q33586578Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry
Q100426886Genetic variants in the regulatory T cell related pathway and colorectal cancer prognosis
Q46432976Genetic variants in the vitamin D receptor gene and prostate cancer risk
Q26775022Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
Q35022825Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q35078297Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36422109Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Q37332589Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk
Q33643330Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry
Q34656420Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry
Q74081659Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: a twin study
Q43167965Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q33609333Genetics for population and public health
Q40755776Genetics of asthma and hay fever in Australian twins.
Q34198753Genetics of epilepsy: The testimony of twins in the molecular era
Q38092403Genetics of febrile seizure subtypes and syndromes: a twin study
Q73485962Genetics of haemostasis
Q45024538Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.
Q36159275Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer
Q39002788Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q30313778Genome-wide analysis identifies 12 loci influencing human reproductive behavior
Q28305142Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q45068755Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q28943520Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
Q35061252Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk
Q28924380Genome-wide association study identifies new prostate cancer susceptibility loci
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q29417131Genome-wide association study identifies novel loci predisposing to cutaneous melanoma
Q37341178Genome-wide association study identifies three loci associated with melanoma risk
Q29416994Genome-wide association study identifies three new melanoma susceptibility loci
Q37140021Genome-wide association study of colorectal cancer identifies six new susceptibility loci
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q91265679Genome-wide association study of peripheral blood DNA methylation and conventional mammographic density measures
Q51764859Genome-wide average DNA methylation is determined in utero.
Q29417001Genome-wide diet-gene interaction analyses for risk of colorectal cancer
Q36190531Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses
Q40636379Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study
Q34321689Genome-wide search for gene-gene interactions in colorectal cancer
Q63977685Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome
Q59566871Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility
Q38823212Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Q34949154Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study
Q33901605Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development
Q57265601Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer
Q37337396Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study
Q35735103Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry
Q59756250Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer
Q45733546Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
Q40200164Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms
Q48178998Growing pains: twin family study evidence for genetic susceptibility and a genetic relationship with restless legs syndrome
Q57100233HFE C282Y Homozygosity Is Associated with an Increased Risk of Total Hip Replacement for Osteoarthritis
Q37274209HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
Q37149526HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity
Q34101222HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis
Q39247003HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women
Q36503369HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Q57306020HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years
Q42626992Hallux Valgus, By Nature or Nurture? A Twin Study
Q35382206Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Q57748112Heavy domestic, but not recreational, physical activity is associated with low back pain: Australian Twin low BACK pain (AUTBACK) study
Q57471595Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q46872589Heritability of macular thickness determined by optical coherence tomography
Q48611340Heritability of mammographic density, a risk factor for breast cancer.
Q52371352Heritable DNA methylation marks associated with susceptibility to breast cancer.
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q35037312Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2
Q34765405Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots
Q39597471High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers
Q35247458High performance computing enabling exhaustive analysis of higher order single nucleotide polymorphism interaction in Genome Wide Association Studies
Q40502668Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study
Q28596814Hormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort study
Q57265814Hormone Replacement Therapy, Percent Mammographic Density, and Sensitivity of Mammography
Q57265782Hormone therapy and breast cancer: what factors modify the association?
Q71382176Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women
Q45288967House dust mite sensitization in toddlers predicts current wheeze at age 12 years
Q45965999How do individuals decide whether to accept or decline an offer of genetic testing for colorectal cancer?
Q37639436How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry
Q35225559How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study
Q39409779Hyperinsulinaemia and obesity in aborigines of south-eastern Australia, with comparisons from rural and urban Europid populations
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q29417155Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Q29416993Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis
Q29417065Identification of IL6R and chromosome 11q13.5 as risk loci for asthma
Q37416078Identification of Lynch syndrome among patients with colorectal cancer
Q37004125Identification of STOML2 as a putative novel asthma risk gene associated with IL6R.
Q37008880Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk
Q36069872Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer
Q29417013Identification of a melanoma susceptibility locus and somatic mutation in TET2.
Q36062033Identification of a novel percent mammographic density locus at 12q24.
Q34975918Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
Q39321320Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q37074763Identification of new genetic risk factors for prostate cancer
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q57170142Identification of nine new susceptibility loci for endometrial cancer
Q36014067Identification of novel genetic markers of breast cancer survival
Q29417022Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Q34048230Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q57305995Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue
Q36335636Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry
Q39314150Impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia in Australian aborigines from the desert
Q38912872Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer
Q57265784In Reply:
Q34185064Incorporation of twins in the regressive logistic model for pedigree disease data
Q40686588Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study.
Q53400538Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.
Q34250215Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
Q37708268Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry
Q57305946Inference about causation between body mass index and DNA methylation in blood from a twin family study
Q34249252Inference about causation from examination of familial confounding: application to longitudinal twin data on mammographic density measures that predict breast cancer risk
Q43199954Influence of high-dose estrogen exposure during adolescence on mammographic density for age in adulthood
Q50352967InforMD: a new initiative to raise public awareness about breast density.
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q44509051Innovations in the statistical analysis of twin studies.
Q48503138Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Q57265634Interleukin-6 promoter variants, prostate cancer risk, and survival
Q51579135International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.
Q35458070International network of twin registries (INTR): building a platform for international collaboration
Q90690238Interval breast cancer risk associations with breast density, family history and breast tissue aging
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q28264901Iron-overload-related disease in HFE hereditary hemochromatosis
Q57265722Is BRCA2 c.9079 G > A a predisposing variant for early onset breast cancer?
Q53227682Is MSH2 a breast cancer susceptibility gene?
Q50109358Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
Q57265815Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?
Q58417105Is benign rolandic epilepsy genetically determined?
Q39581403Is breast cancer risk associated with alcohol intake before first full-term pregnancy?
Q36225575Is childhood immunisation associated with atopic disease from age 7 to 32 years?
Q34480659Is there a positive association between mammographic density and bone mineral density?
Q38955532Is this back pain killing me? All-cause and cardiovascular-specific mortality in older Danish twins with spinal pain
Q64279327Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q36254149Key concepts in genetic epidemiology
Q97595643Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q46590053Lifetime alcohol consumption and upper aero-digestive tract cancer risk in the Melbourne Collaborative Cohort Study
Q47646485Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study
Q39102623Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer
Q52220393Likelihood-based approach to estimating twin concordance for dichotomous traits.
Q43843244Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
Q35000837Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).
Q24802704Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
Q39035043Longitudinal Study of Mammographic Density Measures That Predict Breast Cancer Risk
Q52456412Longitudinal analysis of lung function growth in healthy children and adolescents.
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q53345216Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.
Q24618839Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X
Q34375540Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins
Q33767027Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry
Q35019782MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study
Q35088518MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study
Q57265792Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival
Q44439883Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer
Q48729158Magnetic resonance imaging and late-onset epilepsy.
Q36043843Mammographic breast density and breast cancer: evidence of a shared genetic basis
Q36274404Mammographic breast density as an intermediate phenotype for breast cancer
Q48596722Mammographic densities during the menopausal transition: a longitudinal study of Australian-born women
Q33859833Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide
Q44758736Mammographic density and candidate gene variants: a twins and sisters study
Q37018080Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study
Q47116028Mammographic density and risk of breast cancer by tumor characteristics: a case-control study
Q40232863Mammographic density and risk of breast cancer in Korean women
Q37517477Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems
Q41010078Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk
Q36057738Mammographic density phenotypes and risk of breast cancer: a meta-analysis
Q38194952Mammographic density-a review on the current understanding of its association with breast cancer
Q37358052Mammographic density: a heritable risk factor for breast cancer
Q36337267Meanings of abortion in context: accounts of abortion in the lives of women diagnosed with breast cancer
Q36373793Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer
Q37123422Measuring, and identifying predictors of women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk
Q74459833Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation
Q38463411Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry
Q56435948Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
Q35815677Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk
Q89685277Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk
Q37100729Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
Q30252873Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer
Q56089167Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q93370418Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
Q35784595Mendelian randomization study of height and risk of colorectal cancer
Q70512162Menopausal symptoms in Australian women
Q50016433Menopause-Related Appendicular Bone Loss is Mainly Cortical and Results in Increased Cortical Porosity.
Q34091855Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development
Q36333368Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
Q35670184Meta-analysis of new genome-wide association studies of colorectal cancer risk
Q30558412Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery
Q36208014Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q57265760Microsatellite Instability Markers for Identifying Early-Onset Colorectal Cancers Caused by Germ-Line Mutations in DNA Mismatch Repair Genes
Q47973656Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q42698804Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.
Q57305979Molecular Characterization and Cancer Risk Associated with BRCA1 and BRCA2 Splice Site Variants Identified in Multiple-Case Breast Cancer Families
Q57306007Molecular characterization and cancer risk associated withBRCA1 andBRCA2 splice site variants identified in multiple-case breast cancer families
Q37066133Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening
Q39926554Mother's smoking and complex lung function of offspring in middle age: A cohort study from childhood
Q24658557Multigene testing of moderate-risk genes: be mindful of the missense
Q21144952Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q50582715Multiple loci on 8q24 associated with prostate cancer susceptibility.
Q33988405Multiple loci with different cancer specificities within the 8q24 gene desert
Q28268180Multiple newly identified loci associated with prostate cancer susceptibility
Q30491647Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium
Q40808150Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome
Q36087551Mutation deep within an intron of MSH2 causes Lynch syndrome
Q35972599Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
Q36853854Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis
Q36663501Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study
Q38075521Nature or nurture in low back pain? Results of a systematic review of studies based on twin samples
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q57265727No Association between Common Chemokine and Chemokine Receptor Gene Variants and Prostate Cancer Risk
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q24800108No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer
Q48064622No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study
Q34642008No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk
Q37308596No evidence that GATA3 rs570613 SNP modifies breast cancer risk
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q44122211No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years
Q45834583No strong association between second to fourth digit ratio (2D:4D) and adult anthropometric measures with emphasis on adiposity
Q35752042Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Q56359054Novel Common Genetic Susceptibility Loci for Colorectal Cancer
Q47248476Novel associations between blood DNA methylation and body mass index in middle-aged and older adults
Q44766689Obesity and outcomes in premenopausal and postmenopausal breast cancer
Q51599913Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation.
Q58416998Obstetric Events as a Risk Factor for Febrile Seizures: A Community-Based Twin Study
Q91557009Occupational exposure to solvents and lung function decline: A population based study
Q53559785Occupational exposures to solvents and metals are associated with fixed airflow obstruction.
Q36591738Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations
Q36696565Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
Q34398269Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations
Q45898816P-236Screening practices of Australians at population and familial risk following the partial roll-out of the National Bowel Cancer Screening Program, 2009-2012.
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q34778710PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival
Q33879359Parent of origin effects on age at colorectal cancer diagnosis
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q64126036Parental Education and Genetics of BMI from Infancy to Old Age: A Pooled Analysis of 29 Twin Cohorts
Q51807648Parity and decreased use of oral contraceptives as predictors of asthma in young women.
Q34061135Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry
Q34102606Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study
Q43707600Pedigree analysis of blood pressure in subjects from rural Greece and relatives who migrated to Melbourne, Australia
Q27851443Penetrance analysis of the PALB2 c.1592delT founder mutation
Q37337361Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing
Q36094483Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases
Q35965705Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics
Q33820828Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study
Q89454638Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
Q44277666Physical activity, body size and composition, and risk of ovarian cancer
Q34059662Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study
Q45350463Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk
Q37570238Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q41495374Polymorphisms affecting vitamin D-binding protein modify the relationship between serum vitamin D (25[OH]D3) and food allergy
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q47590869Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics
Q34606248Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
Q73022855Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study
Q35587015Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study
Q45062920Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry
Q36287185Population-based family studies in genetic epidemiology
Q33566677Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study
Q30674792Power of regression and maximum likelihood methods to map QTL from sib-pair and DZ twin data
Q36009831Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk
Q37353677Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry
Q34102617Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models
Q60044938Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
Q92055460Prediction and clinical utility of a contralateral breast cancer risk model
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q40986564Prediction of functional outcome and tissue loss in acute cortical infarction
Q37179473Predictors of mammographic density: insights gained from a novel regression analysis of a twin study
Q40414575Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort
Q46561468Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer
Q36176973Preterm birth and low birth weight continue to increase the risk of asthma from age 7 to 43.
Q30275554Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Q35180844Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom
Q36903452Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
Q57265876Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study
Q38614073Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis
Q57306049Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies
Q57265847Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis
Q37185723Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
Q49072154Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.
Q57265692Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies
Q37331108Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Q38820804Protective and Harmful Effects of Physical Activity for Low Back Pain: A Protocol for the AUstralian Twin BACK Pain (AUTBACK) Feasibility Study
Q37121690Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study
Q35046454Public health aspects of genetic screening for hereditary haemochromatosis in Australia
Q52978550Publication policy or publication bias?
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q90242034Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Q36178929Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.
Q34801092Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry
Q35648055Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk
Q34540638RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study
Q36009422RAD51B in Familial Breast Cancer
Q61132086RESPONSE LETTER TO DR. GAU ET AL
Q73740231RESPONSE: re: HRAS1 rare minisatellite alleles and breast cancer in australian women under age forty years
Q28652308Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Q28652056Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers
Q28730692Rare mutations in XRCC2 increase the risk of breast cancer
Q35608690Rare variants in the ATM gene and risk of breast cancer
Q37373918Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
Q28743906Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
Q36790169Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer
Q57265799Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer
Q52041110Re: "Presenting statistical uncertainty in trends and dose-response relations".
Q54331515Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
Q45151860Re: On the use of familial aggregation in population-based case probands for calculating penetrance
Q73600014Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Q56611123Re: Prospective Studies of Dairy Product and Calcium Intakes and Prostate Cancer Risk: A Meta-Analysis
Q57265637Reasons for ongoing participation in a longitudinal cohort study
Q90439909Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk
Q34964012Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies
Q50787795Red meat, chicken, and fish consumption and risk of colorectal cancer.
Q72113471Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis
Q56436732Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer
Q48018693Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer
Q42658024Regressive logistic modeling of familial aggregation for asthma in 7,394 population-based nuclear families
Q64101959Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Q50908249Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women.
Q37125404Reliability of DNA methylation measures from dried blood spots and mononuclear cells using the HumanMethylation450k BeadArray
Q51421695Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: a twin study.
Q57305959Reply
Q43232465Reply to comment on: 'Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'.
Q47160276Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers
Q45951126Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Q37632099Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
Q54309392Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
Q40925733Retired elite female ballet dancers and nonathletic controls have similar bone mineral density at weightbearing sites
Q57789353Revised Australian national guidelines for colorectal cancer screening: family history
Q35815958Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
Q47638801Risk factors and preventive strategies for breast cancer.
Q48555890Risk factors for breast cancer associated with mammographic features in Singaporean chinese women.
Q36671526Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
Q33641289Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics
Q39162382Risk factors for low back pain: insights from a novel case-control twin study
Q40789385Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.
Q35750765Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry
Q37710973Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer
Q43793012Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q33699887Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers
Q37085786Risk of pancreatic cancer in breast cancer families from the breast cancer family registry
Q57265859Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia)
Q38627833Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
Q37968395Risk prediction models for colorectal cancer: a review
Q50787592Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Q38717239Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Q30492977Risks of Lynch syndrome cancers for MSH6 mutation carriers
Q46763659Risks of cancers for carriers of monoallelic MUTYH mutation with a family history of colorectal cancer
Q36621452Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome
Q36486798Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome
Q34266707Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q36322904SNPs and breast cancer risk prediction for African American and Hispanic women
Q38108742Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis
Q38099956Screening participation predictors for people at familial risk of colorectal cancer: a systematic review
Q36429192Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer
Q35739938Screening practices of unaffected people at familial risk of colorectal cancer
Q34628788Second to fourth digit ratio (2D:4D) and concentrations of circulating sex hormones in adulthood
Q35212668Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study
Q36385301Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study
Q34020691Segregation analyses of 1,476 population-based Australian families affected by prostate cancer
Q40603558Sensitization to milk, egg and peanut from birth to 18 years: A longitudinal study of a cohort at risk of allergic disease
Q59654873Serum Vitamin D and Falls in Older Women in Residential Care in Australia
Q29417074Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Q21999082Sexual factors and prostate cancer
Q50964155Sexuality, hormones and the menopausal transition.
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q46793899Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial
Q51118570Should the grading of colorectal adenocarcinoma include microsatellite instability status?
Q33658220Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center
Q56995007Smoking and prostate cancer: Findings from an Australian case-control study
Q36567692Socio-economic status and survival from breast cancer for young, Australian, urban women
Q50137108Socioeconomic status and cancer mortality and incidence in Melbourne.
Q36405971Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas
Q57306051Stability of BAT26 in Lynch syndrome colorectal tumours
Q98394077Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms
Q71477306Streptokinase increases luxury perfusion after stroke
Q36960378Stroke topography and outcome in relation to hyperglycaemia and diabetes
Q43076184Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators
Q34128569Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma
Q90355497Sunscreen Use and Melanoma Risk Among Young Australian Adults
Q34568530Supercomputing enabling exhaustive statistical analysis of genome wide association study data: Preliminary results
Q33566957TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Q37122297Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Q38842051Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.
Q33534461The 4q27 locus and prostate cancer risk
Q24810265The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women
Q69576158The Australian NHMRC Twin Registry. A resource for the Australian scientific community
Q30882439The Australian Twin Registry
Q46594966The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis
Q36615665The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Q43754304The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q24806109The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
Q36417802The CODATwins Project: The Cohort Description of Collaborative Project of Development of Anthropometrical Measures in Twins to Study Macro-Environmental Variation in Genetic and Environmental Effects on Anthropometric Traits
Q57265871The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer
Q40700905The Charles Perkins Centre's Twins Research Node
Q91178389The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Q64116004The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations
Q47348286The Mental Adjustment to Cancer (MAC) scale: replication and refinement in 632 breast cancer patients
Q57265735The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women
Q35781316The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
Q51129428The age of puberty determines sexual dimorphism in bone structure: a male/female co-twin control study.
Q24797305The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers
Q37391248The association of tumor microsatellite instability phenotype with family history of colorectal cancer
Q40723364The associations between childhood asthma and atopy, and parental asthma, hay fever and smoking
Q51182041The biology of panic-genetic evidence.
Q72714387The bone density of female twins discordant for tobacco use
Q24655454The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Q53335555The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
Q67558093The effect of aging on intact PTH and bone density in women
Q72607251The effect of pregnancy on the epilepsies: a study of 37 pregnancies
Q51620165The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes.
Q33178370The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific
Q51048048The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample.
Q43480606The heritability of mammographically dense and nondense breast tissue
Q46112463The heritability of prostate cancer—letter
Q61974616The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations
Q58198339The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing
Q37681773The interaction between farming/rural environment and TLR2, TLR4, TLR6 and CD14 genetic polymorphisms in relation to early- and late-onset asthma
Q46096589The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age.
Q24806016The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia
Q51439350The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
Q35476902The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry
Q40091643The prevalence and risk factors of epiretinal membranes: the Melbourne Collaborative Cohort Study
Q68110886The prevalence of glucose intolerance in aborigines and Europids of south-eastern Australia
Q43993679The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Q35587027The role of SMAD4 in early-onset colorectal cancer
Q52282627The role of genes in tobacco smoking during adolescence and young adulthood: a multivariate behaviour genetic investigation.
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q38025481The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies
Q46912143The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels
Q43829398The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Q39393845The treatment-seeking woman at menopause
Q34622507The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array
Q51004176The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women.
Q35799767Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studies
Q40239027Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case-control study
Q51887153Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
Q38407261Tracing 8,600 participants 36 years after recruitment at age seven for the Tasmanian Asthma Study
Q34270911Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q41368391Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?
Q51828985Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
Q40713486Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts
Q36924465Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry
Q37003285Tumour morphology predicts PALB2 germline mutation status
Q40080751Twin birth changes DNA methylation of subsequent siblings
Q36622764Twin concordance for a binary trait. I. Statistical models illustrated with data on drinking status
Q35200130Twin concordance for a binary trait. II. Nested analysis of ever-smoking and ex-smoking traits and unnested analysis of a "committed-smoking" trait
Q40767111Twin concordance for a binary trait: III. A bivariate analysis of hay fever and asthma
Q48513343Twin studies for the prognosis, prevention and treatment of musculoskeletal conditions.
Q57242585Twin study of genetic and environmental influences on adult body size, shape and composition
Q43703848Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion
Q37401258Twin's Birth-Order Differences in Height and Body Mass Index From Birth to Old Age: A Pooled Study of 26 Twin Cohorts Participating in the CODATwins Project
Q51974477Two ATM variants and breast cancer risk.
Q92994868Two truncating variants in FANCC and breast cancer risk
Q57265834Use of Molecular Tumor Characteristics to Prioritize Mismatch Repair Gene Testing in Early-Onset Colorectal Cancer
Q37583398Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk
Q36469169Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry
Q57265740Using Mammographic Density to Improve Breast Cancer Screening Outcomes
Q33763777Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model
Q31061546Using bivariate models to understand between- and within-cluster regression coefficients, with application to twin data
Q28394774Using functional data analysis models to estimate future time trends in age-specific breast cancer mortality for the United States and England-Wales
Q30681302Using longitudinal data to define the perimenopause by menstrual cycle characteristics
Q34613556Using mammographic density to predict breast cancer risk: dense area or percentage dense area
Q57265924Validation of Questionnaire and Bronchial Hyperresponsiveness against Respiratory Physician Assessment in the Diagnosis of Asthma
Q36503573Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)
Q47128258Validation study of risk prediction models for female relatives of Australian women with breast cancer
Q56994850Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA
Q46647254Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry
Q37367984Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease
Q48629163Volumetric analysis of cerebral hypoperfusion on SPECT: validation and reliability.
Q47334605Weight change and prostate cancer incidence and mortality
Q40462333Who remembers whether they had asthma as children?
Q34586198Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles
Q47662548Why Accurate Knowledge of Zygosity is Important to Twins
Q74202884Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study
Q63352871Within-family studies for Mendelian randomization: avoiding dynastic, assortative mating, and population stratification biases
Q73050997Yield from colonoscopic screening in people with a strong family history of common colorectal cancer
Q36161705Zygosity Differences in Height and Body Mass Index of Twins From Infancy to Old Age: A Study of the CODATwins Project
Q36678510iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management
Q44458999kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Q59270783‘Next-generation’ genome wide association studies

The articles in Wikimedia projects and languages

      John Hopper (scientist)wikipedia

Search more.